Amgen (AMGN) EPS Growth is 'Healthy', Target Raised - Jefferies
Tweet Send to a Friend
Amgen (NASDAQ: AMGN) is down over 5 percent Wednesday following Q1 results after the close as investors focus on lower ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE